Titre : Hyperthyroïdie

Hyperthyroïdie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Proctectomy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hyperthyroïdie : Questions médicales les plus fréquentes", "headline": "Hyperthyroïdie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hyperthyroïdie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hyperthyroïdie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies de la thyroïde", "url": "https://questionsmedicales.fr/mesh/D013959", "about": { "@type": "MedicalCondition", "name": "Maladies de la thyroïde", "code": { "@type": "MedicalCode", "code": "D013959", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C19.874" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thyréotoxicose", "alternateName": "Thyrotoxicosis", "url": "https://questionsmedicales.fr/mesh/D013971", "about": { "@type": "MedicalCondition", "name": "Thyréotoxicose", "code": { "@type": "MedicalCode", "code": "D013971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C19.874.397.685" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Crise thyréotoxique", "alternateName": "Thyroid Crisis", "url": "https://questionsmedicales.fr/mesh/D013958", "about": { "@type": "MedicalCondition", "name": "Crise thyréotoxique", "code": { "@type": "MedicalCode", "code": "D013958", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C19.874.397.685.905" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Hyperthyroïdie", "alternateName": "Hyperthyroidism", "code": { "@type": "MedicalCode", "code": "D006980", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "M Trebillod", "url": "https://questionsmedicales.fr/author/M%20Trebillod", "affiliation": { "@type": "Organization", "name": "Service d'Endocrinologie, CHU Liège, Belgique." } }, { "@type": "Person", "name": "P Pétrossians", "url": "https://questionsmedicales.fr/author/P%20P%C3%A9trossians", "affiliation": { "@type": "Organization", "name": "Service d'Endocrinologie, CHU Liège, Belgique." } }, { "@type": "Person", "name": "Priya Vaidyanathan", "url": "https://questionsmedicales.fr/author/Priya%20Vaidyanathan", "affiliation": { "@type": "Organization", "name": "Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC 20010, USA. Electronic address: pvaidyan@childrensnational.org." } }, { "@type": "Person", "name": "David L Panciera", "url": "https://questionsmedicales.fr/author/David%20L%20Panciera", "affiliation": { "@type": "Organization", "name": "Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA." } }, { "@type": "Person", "name": "Katie M Boes", "url": "https://questionsmedicales.fr/author/Katie%20M%20Boes", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Tumor thrombus formation in the right common iliac vein after radical proctectomy in a patient with rectal cancer: a case report.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36038866", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12893-022-01768-9" } }, { "@type": "ScholarlyArticle", "name": "Patient and surgeon preferences for early ileostomy closure following restorative proctectomy for rectal cancer: why aren't we doing it?", "datePublished": "2022-10-04", "url": "https://questionsmedicales.fr/article/36195816", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00464-022-09580-5" } }, { "@type": "ScholarlyArticle", "name": "A National Cancer Database analysis of the predictors of unplanned 30-day readmission after proctectomy for rectal adenocarcinoma: The CCF RETURN-30 Score.", "datePublished": "2022-12-05", "url": "https://questionsmedicales.fr/article/36473745", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.surg.2022.10.034" } }, { "@type": "ScholarlyArticle", "name": "Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36048196", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00384-022-04245-0" } }, { "@type": "ScholarlyArticle", "name": "Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer.", "datePublished": "2023-06-22", "url": "https://questionsmedicales.fr/article/37349711", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-023-11083-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies endocriniennes", "item": "https://questionsmedicales.fr/mesh/D004700" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la thyroïde", "item": "https://questionsmedicales.fr/mesh/D013959" }, { "@type": "ListItem", "position": 4, "name": "Hyperthyroïdie", "item": "https://questionsmedicales.fr/mesh/D006980" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hyperthyroïdie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hyperthyroïdie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hyperthyroïdie", "description": "Comment diagnostiquer l'hyperthyroïdie ?\nQuels examens sont utilisés pour confirmer l'hyperthyroïdie ?\nQuels symptômes indiquent une hyperthyroïdie ?\nQuel rôle joue la TSH dans le diagnostic ?\nPeut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Proctectomy&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hyperthyroïdie", "description": "Quels sont les symptômes courants de l'hyperthyroïdie ?\nL'hyperthyroïdie cause-t-elle des problèmes de sommeil ?\nComment l'hyperthyroïdie affecte-t-elle le poids ?\nY a-t-il des symptômes oculaires associés ?\nL'hyperthyroïdie peut-elle causer des palpitations ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Proctectomy&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hyperthyroïdie", "description": "Peut-on prévenir l'hyperthyroïdie ?\nLes antécédents familiaux influencent-ils le risque ?\nLe stress peut-il déclencher l'hyperthyroïdie ?\nUne alimentation équilibrée aide-t-elle ?\nLes carences en iode sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Proctectomy&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hyperthyroïdie", "description": "Quels traitements existent pour l'hyperthyroïdie ?\nComment fonctionnent les médicaments antithyroïdiens ?\nQuand est-ce que la chirurgie est nécessaire ?\nL'iode radioactif est-il un traitement efficace ?\nQuels effets secondaires peuvent avoir les traitements ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Proctectomy&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hyperthyroïdie", "description": "Quelles sont les complications de l'hyperthyroïdie ?\nL'hyperthyroïdie peut-elle causer des problèmes cardiaques ?\nQu'est-ce qu'une crise thyroïdienne ?\nComment l'hyperthyroïdie affecte-t-elle les os ?\nY a-t-il des risques de complications psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Proctectomy&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hyperthyroïdie", "description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque d'hyperthyroïdie ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes traitements antérieurs de la thyroïde augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Proctectomy&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hyperthyroïdie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de TSH et T4 libre." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour confirmer l'hyperthyroïdie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des scintigraphies thyroïdiennes et des échographies peuvent être réalisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une hyperthyroïdie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent perte de poids, nervosité, palpitations et insomnie." } }, { "@type": "Question", "name": "Quel rôle joue la TSH dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une TSH basse indique souvent une hyperthyroïdie, car la thyroïde est hyperactive." } }, { "@type": "Question", "name": "Peut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes doivent être confirmés par des tests sanguins." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'hyperthyroïdie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, irritabilité, tremblements et transpiration excessive." } }, { "@type": "Question", "name": "L'hyperthyroïdie cause-t-elle des problèmes de sommeil ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des insomnies et des troubles du sommeil." } }, { "@type": "Question", "name": "Comment l'hyperthyroïdie affecte-t-elle le poids ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle provoque souvent une perte de poids malgré un appétit accru." } }, { "@type": "Question", "name": "Y a-t-il des symptômes oculaires associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes oculaires comme l'exophtalmie peuvent survenir." } }, { "@type": "Question", "name": "L'hyperthyroïdie peut-elle causer des palpitations ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les palpitations cardiaques sont un symptôme fréquent." } }, { "@type": "Question", "name": "Peut-on prévenir l'hyperthyroïdie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial de maladies thyroïdiennes augmente le risque." } }, { "@type": "Question", "name": "Le stress peut-il déclencher l'hyperthyroïdie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut aggraver les symptômes, mais n'est pas une cause directe." } }, { "@type": "Question", "name": "Une alimentation équilibrée aide-t-elle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé thyroïdienne, mais ne prévient pas l'hyperthyroïdie." } }, { "@type": "Question", "name": "Les carences en iode sont-elles un facteur de risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'excès d'iode est plus souvent lié à l'hyperthyroïdie que la carence." } }, { "@type": "Question", "name": "Quels traitements existent pour l'hyperthyroïdie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les médicaments antithyroïdiens, l'iode radioactif et la chirurgie." } }, { "@type": "Question", "name": "Comment fonctionnent les médicaments antithyroïdiens ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils inhibent la production d'hormones thyroïdiennes par la glande thyroïde." } }, { "@type": "Question", "name": "Quand est-ce que la chirurgie est nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée si les autres traitements échouent ou en cas de goitre volumineux." } }, { "@type": "Question", "name": "L'iode radioactif est-il un traitement efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est souvent utilisé pour détruire les cellules thyroïdiennes hyperactives." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent avoir les traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent des éruptions cutanées, des douleurs articulaires et des troubles hépatiques." } }, { "@type": "Question", "name": "Quelles sont les complications de l'hyperthyroïdie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes cardiaques, l'ostéoporose et la crise thyroïdienne." } }, { "@type": "Question", "name": "L'hyperthyroïdie peut-elle causer des problèmes cardiaques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des arythmies et une insuffisance cardiaque." } }, { "@type": "Question", "name": "Qu'est-ce qu'une crise thyroïdienne ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "C'est une urgence médicale avec une augmentation soudaine des hormones thyroïdiennes." } }, { "@type": "Question", "name": "Comment l'hyperthyroïdie affecte-t-elle les os ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner une diminution de la densité osseuse, augmentant le risque d'ostéoporose." } }, { "@type": "Question", "name": "Y a-t-il des risques de complications psychologiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hyperthyroïdie peut provoquer anxiété et dépression chez certains patients." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de maladies thyroïdiennes." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque d'hyperthyroïdie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer une hyperthyroïdie que les hommes." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la maladie de Graves augmentent le risque d'hyperthyroïdie." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 60 ans." } }, { "@type": "Question", "name": "Les traitements antérieurs de la thyroïde augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements comme la radiothérapie peuvent augmenter le risque d'hyperthyroïdie." } } ] } ] }

Sources (142 au total)

Tumor thrombus formation in the right common iliac vein after radical proctectomy in a patient with rectal cancer: a case report.

Intravascular tumor thrombi are mainly found in patients with liver cancer or renal carcinoma but rarely occur in those with rectal cancer.... This is a case report of a 58-year-old woman with a swollen right lower extremity 14 months after radical resection for rectal cancer. Although ultrasonography indicated the presence of deep venous th... The correct diagnosis of a tumor thrombus and its differentiation from DVT can prevent incorrect treatment and prolong the survival of patients with rectal cancer....

Patient and surgeon preferences for early ileostomy closure following restorative proctectomy for rectal cancer: why aren't we doing it?

Early ileostomy closure (EIC), ≤ 2 weeks from creation, is a relatively new practice. Multiple studies have demonstrated that this approach is safe, feasible, and cost-effective. Despite the demonstra... A mixed-methods, cross-sectional study of patients and surgeons was performed. Rectal cancer survivors from a single institution who underwent restorative proctectomy with diverting loop ileostomy and... Forty-eight patients were surveyed (mean age 65.1 ± 11.8 years; 54.2% male). Stoma closure occurred after a median of 7.7 months (IQR 4.8-10.9) and 50.0% (24) found it "difficult" or "very difficult" ... Implementing EIC poses many logistical challenges. Both patients and surgeons are interested in further exploring EIC and believe it warrants a North American RCT to motivate a change in practice....

A National Cancer Database analysis of the predictors of unplanned 30-day readmission after proctectomy for rectal adenocarcinoma: The CCF RETURN-30 Score.

Unplanned 30-day readmission is common after major surgery, including rectal cancer surgery. The present study aimed to assess the rate and predictors of unplanned 30-day readmission after proctectomy... This was a retrospective case-control study using data from the National Cancer Database. Patients with non-metastatic rectal cancer who underwent proctectomy were included, and patients who required ... A total of 55,181 patients (60.9% men) with a mean age of 61.2 years were included. The 30-day readmission rate was 7.07% (95% confidence interval: 6.9-7.3). A Charlson score of 0 (odds ratio: 0.75, P... Comorbidities, residence in urban or rural areas, neoadjuvant radiation therapy, pull-through coloanal anastomosis, conversion to open surgery, and extended hospital stay were predictive of a higher r...

Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study.

This study sought to determine whether adjuvant chemotherapy (AC) compared to no AC (noAC) after neoadjuvant chemoradiation (CRT) and resection for rectal adenocarcinoma prolongs survival. Current gui... A total of 19,867 patients met inclusion/exclusion criteria. Mean age was 58.6 ± 12.0 years, and 12,396 (62.4%) were males. Complete response (CR) was documented in 3801 (19.1%) patients and 8167 (41.... AC was associated with improved OS in patients who received neoadjuvant CRT followed by proctectomy for clinical stages II and III rectal adenocarcinoma. This effect persisted irrespective of patholog... AC following neoadjuvant CRT and surgery is associated with improved OS in patients with rectal adenocarcinoma. These findings warrant adoption of AC after neoadjuvant CRT and surgery for clinical sta...

Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer.

To the best of our knowledge, no previous studies have explored the relationship between visceral obesity and malnutrition. Therefore, this study has aimed to investigate the association between them ... Patients with rectal cancer who underwent proctectomy were included. Malnutrition was defined according to the Global Leadership Initiative on Malnutrition (GLIM). Visceral obesity was measured using ... This study enrolled 624 patients. 204 (32.7%) patients were included in the well-nourished non-visceral obesity (WN) group, 264 (42.3%) patients were included in the well-nourished visceral obesity (W... This study demonstrated that the combination of visceral obesity and malnutrition resulted in higher postoperative complication and mortality rates and was a good indicator of poor prognosis in patien...

Functional outcomes of transanal versus transabdominal restorative proctectomy with ileal pouch-anal anastomosis in ulcerative colitis-a monocentric retrospective comparative study.

Ileal pouch-anal anastomosis (IPAA) ensures satisfactory gastro-intestinal function and quality of life (QoL) in patients with refractory ulcerative colitis (UC). The transanal approach to proctectomy... This is a retrospective study of consecutive UC patients who underwent IPAA between 2011 and 2017, operated according to a modified 2- or 3-stage approach. Close rectal dissection was performed in Ta-... One hundred and eight patients were included: 38 patients had Ta-IPAA. At 12 months follow-up, mean OS and PFS were 4.6 (CI 3.2-6.0) vs 6.2 (CI 5.0-7.3), p = 0.025 and 6.1 (CI 3.5-8.8) vs 7.4 (CI 5.4-... At 12 months postoperatively, pouch function and QoL of Ta-IPAA are probably as good as those of Tabd-IPAA. Limitations include retrospectivity, differences in the surgical technique, and lack of vali...

The impact of restorative proctectomy versus permanent colostomy on health-related quality of life after rectal cancer surgery using the patient-generated index.

The impact of bowel dysfunction versus colostomy on quality of life after rectal cancer surgery is poorly understood.... To evaluate the quality of life after rectal cancer surgery in patients with colostomy versus restorative proctectomy.... A mixed-methods study measuring quality of life using the Patient-Generated Index, patients were asked to list up to 5 areas of their life affected by their surgery. Areas were then weighted according... Overall, 121 patients were included (colostomy n = 39, restorative proctectomy n = 82). There were no differences in demographics, neoadjuvant radiotherapy, or time to follow-up between groups. In the... Colostomy has a more detrimental impact on quality of life than restorative proctectomy. However, bowel dysfunction severity is important to consider. The patient experience between treatments differs...

Local excision vs. proctectomy in patients with ypT0-1 rectal cancer following neoadjuvant therapy: a propensity score matched analysis of the National Cancer Database.

We aimed to evaluate outcomes of organ preservation by local excision (LE) compared to proctectomy following neoadjuvant therapy for rectal cancer.... This retrospective observational study using the National Cancer Database (NCDB) included patients with locally advanced non-metastatic rectal cancer (ypT0-1 tumors) treated with neoadjuvant therapy b... 11,256 of 318,548 patients were included, 526 (4.6%) of whom underwent LE. After matching, mean 5-year OS was similar between the groups (54.1 vs. 54.2 months; p = 0.881). Positive resection margins (... Our findings show no overall significant survival difference between LE and total mesorectal excision, including ypT1 tumors. Moreover, patients with poorly differentiated or mucinous adenocarcinomas ...

Diagnostic accuracy of water-soluble contrast enema, contrast-enema computed tomography and endoscopy in detecting anastomotic leakage after (Colo) proctectomy: A meta-analysis.

Anastomotic leakage (AL) as a result of creation of a colorectal/anal anastomosis still represents a frequent complication of colorectal surgery, with short- and long-term consequences on postoperativ... A systematic review and meta-analysis of 19 studies accounting for a total of 25 tests reporting diagnostic accuracy estimates was conducted following the Preferred Reporting Items for Systematic Revi... For WSCE, the pooled sensitivity was 0.50, the pooled specificity was 0.99 and the area under the curve (AUC) was 0.91. For endoscopy, the pooled sensitivity was 0.69, specificity was 1.00 and AUC was... Water-soluble contrast enema, endoscopy and CECT have an elevated diagnostic accuracy. However, WSCE is less accurate than either endoscopy or CECT. Although greater sensitivity was demonstrated for C...

Robotic Proctectomy: Beyond the Initial Learning Curve.

Multiple authors have described an initial learning curve (LC) for robotic proctectomy (RP), but there is scant literature regarding continued technical progression beyond this stage. Total operating ... We reviewed our robotic surgery database for a single surgeon during operations 100 through 550 to identify 83 RPs for tumor. These were divided into quartiles by series order, indicating surgeon expe... From March 2014 through March 2019, 450 robotic colorectal operations were performed, including 83 RPs for polyp or cancer. No significant differences were found among the quartiles in regard to demog... ICA became a routine part of RP after the initial LC, with increases in TOT and PCT. Number of lymph nodes increased and number and severity of complications decreased with experience. Increased PCT m...